Abstract

Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations

Author(s): Allen Loyd V Jr

Issue: Jul/Aug 1997 - Compounding for Animals

Page(s): 233-234

Download in electronic PDF format for $75

Abstract

This article discusses the factors that influence drug concentration in animals, including absorption, distribution, metabolism and excretion. Tables provide information regarding body composition of various animals, including humans; half-lives in hours of selected drugs in animals; drug dosage variations of different animals for two different drugs administered by the intramuscular and intravenous routes and pharmacokinetic parameters of diazepam in the human, dog and rat.

Related Keywords

Related Categories

Printer-Friendly Version

Related Articles from IJPC

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2003 Pg. 106-113	Veterinary Transdermal Medications: A to Z Author(s): Davidson Gigi S
Jul/Aug 1997 Pg. 233-234	Compounding for Veterinary Patients: Pharmaceutical, Biopharmaceutical, Pharmacokinetic and Physiologic Considerations Author(s): Allen Loyd V Jr
Jan/Feb 2014 Pg. 6-12	The Role of Compounding in Closing Therapeutic Gaps--Abstracts from FIP 2013 Author(s): Lutz Eugene, Pauletti Giovanni, Carvalho Maria, Davidson Gigi, Ashworth Lisa, Subramaniam Vaiyapuri, Llambí Francesc
Jul/Aug 2000 Pg. 264-272	Providing Positive Outcomes through Compounding for Animal Cancer Patients Author(s): Davidson Gigi S
May/Jun 2004 Pg. 181-185	Compounding in the Pharmacy Curriculum: Beyond the Basics Author(s): Hinkle Amanda R, Newton Gail D
Jan/Feb 2017 Pg. 19-21	When to Compound Medications for Veterinary Patients Author(s): Forsythe Lauren Eichstadt
Sep/Oct 2016 Pg. 367-374	Pharmaceutical Compounding: The Oldest, Most Symbolic, and Still Vital Part of Pharmacy Author(s): Kochanowska-Karamyan Anna J
Nov/Dec 2003 Pg. 441-447	Single-Patient Trials, Extemporaneously Compounded Products and Pharmaceutical Care Author(s): Fassett William E
Jul/Aug 2010 Pg. 328-331	Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program Author(s): Okeke Claudia C, Allen Loyd V Jr
Sep/Oct 2019 Pg. 428-433	The Current Landscape of Veterinary Compounding in the Veterinary Setting Author(s): Gochenauer Alexandria E, Rishniw Mark, Holmes Erin R, Forsythe Lauren R
Jul/Aug 2015 Pg. 303-305	U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Author(s): Miller David G
Mar/Apr 2014 Pg. 101-111	Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Author(s): Timko Robert J, Crooker Philip EM
Sep/Oct 2007 Pg. 412	Calculations: Compounding for Veterinary Patients Author(s): Stockton Shelly J
Mar/Apr 1997 Pg. 84-86	Compounding for the Pediatric Patient Author(s): Allen Loyd V Jr
Mar/Apr 2017 Pg. 111-115	Consultation for Human, Veterinary, and Compounded Medications Author(s): Moghadam Gabriella, Forsythe Lauren Eichstadt
Sep/Oct 2009 Pg. 390-391	Recommended Tips for Treating Veterinary Patients Author(s): Bramwell Bethany L, Williams LaVonn A
Jan/Feb 2022 Pg. 34-38	Basics: Considerations and Background Information for Counseling Patients Using Compounded Suppositories Author(s): Allen Loyd V Jr
Jan/Feb 2009 Pg. 42-49	Compounding for Cancer in Companion Animals Author(s): Mixon William, Northrup Nicole, Vail Jane
Jul/Aug 2004 Pg. 277-283	Veterinary Ophthalmic Practice: Therapeutic Considerations and Common Ocular Diseases - Part 2 Author(s): Davidson Gigi S
May/Jun 2005 Pg. 178-182 View Sample	Update on Transdermals for Animal Patients Author(s): Davidson Gigi S